// App-Quantinova.ai

5558 : Improving the prediction of surgical outcome at secondary cytoreduction in patients with ovarian cancer: Results from retrospective part of HELP-ER study NOGGO TR2/ENGOT OV47-TR.

Researchers

Presenter

  • Ioana Braicu

Principal Investigators

  • Wanja Nikolai Kassuhn

  • Hagen Kulbe

  • Pauline Wimberger

  • Cagatay Taskiran

  • Klaus Pietzner

  • Alexander Mustea

  • Robert Armbrust

  • J.P. P. Grabowski

  • Felix Schmidt

  • Ali Ayhan

  • Carmen Rosa Beteta

  • Christina Fotopoulou

  • Jalid Sehouli

Medical Centers

  • North-Eastern German Society of Gynecological Oncology (NOGGO) and Department of Gynecology with Center for Oncological Surgery, Charité–University Medicine of Berlin, Campus Virchow Klinikum, Berlin, Germany

  • Charité Medizinische Universitaet Berlin, Department of Gynecology, Campus Virchow, Berlin, Germany

  • Charite Medizinische Universitat Berlin, Berlin, Germany

  • North-Eastern German Society of Gynecological Oncology (NOGGO) and Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany

  • Department of Medical Oncology, Kocaeli University School of Medicine, Istanbul, Turkey

  • Charite Universitatsmedizin Berlin, Department of Gynaecology, European Competence Center for Ovarian Cancer, Charite Campus Virchow Klinikum, Berlin, Germany

  • Department of Gynecology and Gynecological Oncology, University Hospital, Bonn, Germany

  • , Campus Virchow Clinic, Berlin, Germany

  • Charité Universitätsmedizin Berlin, Clinic for Gynecology, Campus Virchow Klinikum, Berlin, Germany

  • Gazi University Hospital, Ankara, Turkey

  • Department of Gynecology, Charite Medicine University, Berlin, Berlin, Germany

Locations

  • Germany

  • Turkey

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Gynaecological cancer

Biomarkers

  • Human epididymis secretory protein 4

  • Carbohydrate antigen 125

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A